Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
1977-6-22
|
pubmed:abstractText |
Methotrexat (250-1100 mg/m2) was administered to 38 patients with malignant tumors by infusion of either 6 hours or of 75 minutes duration. MTX-infusion and continued at 3-6 hours interval for Citrovorum factor rescue was started 2 hours after 24 to 72 hours. 7 different MTX doses and rescue schedules were tested. It could be shown that MTX in the dose range used is effective in various tumors when CF-rescue is not higher than 7% of the administered MTX-dose, only occasionally therapeutic success was observed with higher doses. In the group of patients where CF-rescue was lower than 7% of the MTX dose on 9/14 patients objective tumor-regressions could be achieved. Conclusions drawn are discussed and the necessity of further investigations is emphasized.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0377-2004
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
141-8
|
pubmed:dateRevised |
2008-2-28
|
pubmed:meshHeading |
pubmed-meshheading:300863-Administration, Oral,
pubmed-meshheading:300863-Adult,
pubmed-meshheading:300863-Aged,
pubmed-meshheading:300863-Female,
pubmed-meshheading:300863-Humans,
pubmed-meshheading:300863-Injections, Intramuscular,
pubmed-meshheading:300863-Injections, Intravenous,
pubmed-meshheading:300863-Leucovorin,
pubmed-meshheading:300863-Male,
pubmed-meshheading:300863-Methotrexate,
pubmed-meshheading:300863-Middle Aged,
pubmed-meshheading:300863-Neoplasms
|
pubmed:year |
1977
|
pubmed:articleTitle |
[Therapy of solid tumors using high-dose methotrexate and citrovorum factor].
|
pubmed:publicationType |
Journal Article,
English Abstract
|